18 August 2016 13:00 New external board appointment Listing Rule LR 9.6.14 R (2) Graham Chipchase, a Non-Executive Director of AstraZeneca PLC, has been appointed as Chief Executive Officer and a Director of Brambles Limited, a company listed on the Australian Securities Exchange, effective from 2017. About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com CONTACTS Media Enquiries Neil UK/Global +44 203 749 5637 Burrows Vanessa UK/Global +44 203 749 5736 Rhodes Karen UK/Global +44 203 749 5634 Birmingham Rob UK/Global +44 203 749 5821 Skelding Jacob Lund Sweden +46 8 553 260 20 Michele US +1 302 885 2677 Meixell Investor Relations UK Thomas Kudsk +44 203 749 5712 Larsen Craig Marks Finance, Fixed Income, M&A +44 7881 615 764 Nick Stone Respiratory & Autoimmunity +44 203 749 5716 Henry Oncology +44 203 749 5797 Wheeler Christer Infection & Neuroscience +44 203 749 5711 Gruvris US Lindsey Cardiovascular & Metabolic Diseases +1 240 543 7970 Trickett Mitchell Oncology +1 240 477 3771 Chan Toll-free +1 866 381 7277 Adrian Kemp Company Secretary AstraZeneca PLC -ENDS-
Director Declaration
| Source: AstraZeneca PLC
Pièces jointes
